Provided by Tiger Trade Technology Pte. Ltd.

ResMed

220.47
-2.0300-0.91%
Post-market: 219.40-1.0700-0.49%17:54 EDT
Volume:985.00K
Turnover:217.34M
Market Cap:32.18B
PE:21.81
High:222.51
Open:222.51
Low:219.57
Close:222.50
52wk High:293.81
52wk Low:199.92
Shares:145.97M
Float Shares:145.51M
Volume Ratio:0.83
T/O Rate:0.68%
Dividend:2.33
Dividend Rate:1.06%
EPS(TTM):10.11
EPS(LYR):9.55
ROE:25.68%
ROA:14.75%
PB:5.09
PE(LYR):23.09

Loading ...

ResMed CFO Brett Sandercock Reports Disposal of Common Shares

Reuters
·
Jan 06

144 Report of proposed sale of securities-RMD.N

Reuters
·
Jan 06

Resmed Inc-144 Report of Proposed Sale of Securities

THOMSON REUTERS
·
Jan 06

ResMed Global General Counsel Michael J. Rider Reports Disposal of Common Shares

Reuters
·
Jan 06

I'm afraid my financial adviser will steal my money. I've read too many cautionary tales. How can I be sure?

Dow Jones
·
Jan 04

ResMed Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Jan 03

ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 69% of the company

Simply Wall St.
·
Jan 02

I'm afraid my financial adviser will steal my money. I've read too many cautionary tales. How can I be sure?

Dow Jones
·
Dec 31, 2025

I'm afraid my financial adviser will steal my money. I've read too many cautionary tales. How can I be sure?

Dow Jones
·
Dec 28, 2025

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
Dec 19, 2025

Stifel Nicolaus Adjusts ResMed Price Target to $260 From $270, Maintains Hold Rating

MT Newswires Live
·
Dec 19, 2025

ResMed Is Maintained at Hold by Stifel

Dow Jones
·
Dec 18, 2025

Resmed Inc : Stifel Cuts Target Price to $260 From $270

THOMSON REUTERS
·
Dec 18, 2025

ResMed Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
Dec 17, 2025

Baird Downgrades ResMed to Neutral From Outperform, Adjusts Price Target to $275 From $300

MT Newswires Live
·
Dec 16, 2025

ResMed Cut to Neutral From Outperform by Baird

Dow Jones
·
Dec 16, 2025

Assessing LivaNova (LIVN)’s Valuation After Hiring ResMed Veteran to Lead Sleep Apnea Commercialization

Simply Wall St.
·
Dec 15, 2025

ResMed Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Dec 11, 2025

S&P 500 Futures Decline In Premarket Trading; Louisiana-Pacific, GameStop Lag

Dow Jones
·
Dec 10, 2025

Resmed Inc-4 Statement of Changes in Beneficial Ownership

THOMSON REUTERS
·
Dec 10, 2025